Blog

The Toyota Fortuner Facelift is finally on sale in India and brings comprehensive upgrades to the popular SUV. The changes comprise a heavily revised front with a larger grille, new bumper, revamped LED projector headlamps with a new signature pattern for the LED DRLs. The SUV also gets new alloy wheels and taillight design to differentiate it over the pre-facelift model. The cabin has been updated with new features that make the SUV more future-ready and on par with some of its rivals. With the revision in aesthetics and features, prices have been revised on the new Fortuner facelift and…

Nissan India announced a price hike of up to 5% across its models. The revised prices will be applicable across all available models for Nissan and Datsun, effective January 2021. Nissan KICKS was launched with most powerful engine producing 156ps power. The Nissan KICKS is available in 1.5L Naturally Aspirated & 1.3L Turbo petrol engine option with MT & CVT option. The Datsun redi-GO is available in 0.8L & 1.0L engine option and in MT & AMT variants. Datsun GO is available in 1.2L engine option with MT & CVT options. The Datsun GO+ is available in 1.2L engine option…

Amidst the Covid-19 pandemic, aiming to encourage health and safety, RSPL Group, manufacturers and marketers of Ghadi – India’s no. 1 detergent powder – unveiled its all-new #BachaavMeinHiSamajhdaariHai campaign. Ghadi detergent is India’s first brand to create awareness through its packaging. India’s first awareness initiative via packaging aims to reach more than 10-crore Indian households. They will be reminded of always wearing a face mask and to be more responsible and committed to public safety. The awareness initiative will be showcased on the Ghadi detergent packet wherein the actual logo is covered with a printed mask. In addition to the…

A fixed-dose combination (FDC) of Sodium-Glucose Co-Transporter Inhibitor (SGLT2i) - Remogliflozin Etabonate and Vildagliptin has been launched by Glenmark Pharmaceuticals Limited in India. The fixed drug combination is indicated for the management of Type 2 diabetes. The combination will contain Remogliflozin (100 mg) + Vildagliptin (50 mg) in a fixed-dose and must be taken twice daily. Glenmark has launched the same under two brand names Remo V and Remozen V. In the world, Glenmark is the first company to launch Remogliflozin + Vildagliptin fixed dose combination and India is the first country to get access to this FDC drug. Glenmark…